相关实验视频
Updated: May 15, 2025

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
Published on: January 22, 2020
ICI诱导的心血管毒性:机制和免疫重编程治疗策略
Jixuan Zheng1, Yanyu Yi1, Tingchen Tian1
1Department of Reproductive Medicine, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, West China School of Medicine, West China School of Pharmacy, Sichuan University, Chengdu, China.
免疫检查点抑制剂 (ICI) 可以引起心血管毒性,如肌心炎和动脉样硬化,由于免疫细胞重编程. 针对免疫重编程的策略可以减轻这些不良事件,提高癌症治疗的安全性.
科学领域:
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 免疫检查点抑制剂 (ICI) 已经改变了癌症治疗.
- 与免疫相关的不良事件 (irAEs),特别是心血管毒性,是令人担忧的重大问题.
- 由ICI引起的心血管问题包括肌心炎和动脉样硬化,由免疫过度激活驱动.
研究的目的:
- 探索ICI诱导心血管毒性的机制.
- 为了突出免疫重编程的保护潜力.
- 强调T细胞和巨细胞重编程在心血管健康中的作用.
主要方法:
- 对ICI诱导的心血管毒性现有文献的审查.
- 对免疫细胞重编程 (T细胞,巨细胞) 在病原发生过程中的分析.
- 检查针对代谢途径和信号的治疗策略.
主要成果:
- 在ICI引起的心血管并发症中,T细胞和巨细胞的重编程是关键因素.
- 针对糖解,脂肪酸氧化和ROS生产的目标显示出有希望.
- 免疫重编程影响短期和长期的心血管调节.
结论:
- 了解免疫重编程是管理ICI诱导心血管毒性的关键.
- 针对免疫细胞重编程,为更安全的癌症治疗提供了创新的策略.
- 进一步的研究可以提高ICI的安全性和患者的治疗结果.
更多相关视频
08:17A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research
Published on: August 15, 2019
11:34A Simple and Efficient Method for Testing Immunomodulatory Agents for Generation of Tolerogenic Dendritic Cells from Human CD14+ Monocytes
Published on: April 11, 2025
相关概念视频
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cell-mediated Immune Responses
Heart Failure Drugs: Inotropic Agents
Tumor Immunotherapy